Syndax Pharmaceuticals, Inc. (SNDX)
23.68
-0.09
(-0.38%)
USD |
NASDAQ |
Mar 18, 15:59
23.67
-0.01
(-0.04%)
After-Hours: 19:22
Syndax Pharmaceuticals Shareholders Equity (Quarterly) : 64.63M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Biogen, Inc. | 18.26B |
| Cogent Biosciences, Inc. | 636.37M |
| ACADIA Pharmaceuticals, Inc. | 1.227B |
| Alnylam Pharmaceuticals, Inc. | 789.18M |
| Savara, Inc. | 203.13M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 529.71M |
| Total Liabilities (Quarterly) | 465.08M |
| Debt to Equity Ratio | 5.345 |
| Current Ratio | 4.396 |
| Net Debt Paydown Yield | -3.75% |